Skip to main content

ALS Research

Dr. Angela Genge with her team at The Neuro (Montreal Neurological Institute-Hospital)

ALS Research

Dr. Angela Genge with her team at the Neuro (Montreal Neurological Institute- Hospital)

Read about Dr. Angela Genge's Research

Approximately 4,000 Canadians are living with amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. Brain Canada funds cutting-edge research that could support better diagnosis and treatment to improve the lives of people living with ALS.

Our Projects

$35,096,718
invested

Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.

Search the directory

125
grants awarded

Our Partners

View all our partners

Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting ALS research include:

ALS Society of Canada (ALS Canada)

Visit site

Alnylam Pharmaceuticals Inc.

Visit site

Regeneron Pharmaceuticals Inc.

Visit site

How you can help

Brain Canada funds the very best Canadian neuroscience, fostering collaborative research and accelerating the pace of discovery, in order to improve the health and quality of life of Canadians who suffer from brain disorders.

Learn more

Donate now